🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Spain / NCT07103343
Active, not recruiting Not applicable

MOVI-OLE! [Open Learning Environments]

NCT07103343 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2026-04-13

Condition(s) studied

Sedentary BehaviorPhysical ActivityCognitive FunctionMental HealthChildhood ObesityAcademic PerformanceExecutive FunctionHealth-Related Quality of LifeSchool EngagementCardiometabolic RiskClassroom DesignEducational InnovationPhysical FitnessBlood PressureAdiposityPsychological Well-Being

Investigational drug(s) / intervention(s)

MOVI-OLE intervention

MOVI-OLE intervention: In the MOVI-OLE! classrooms, traditional desks and chairs will be replaced by three dynamic learning zones: A) Dynamic seating: an area with traditional wheeled desks combined with dynamic seats such as fitballs, stools, pedal desks, etc.; B) Standing desks: an area with manually adjustable high desks to allow standing work. Students will also have stools with small backrests and footrests for when they need to sit; C) Vertical boards: vertical boards (vinyl, paper, chalkboard paint, etc.) installed on walls for standing work. To facilitate use and adapt to classroom routines, teachers will decide how to distribute students among the different zones, with the requirement that all students spend at least 20 minutes per school day in zone B. In addition to the workstations, teachers will receive training and didactic support materials focused on student-centered methodologies and the use of open learning spaces.

Study summary

This study will evaluate the effectiveness of MOVI-OLE! (Open Learning Environment), a school-based intervention designed to reduce sedentary time and enhance multiple aspects of child development, including cognitive function, physical fitness, body composition, psychological well-being, and student engagement. The intervention combines dynamic classroom furniture with student-centered teaching practices. Additionally, a qualitative component will explore how students, teachers, and families perceive the feasibility and acceptability of implementing MOVI-OLE! in real-world school settings.

Eligibility

Sex
ALL
Min age
9 Years
Max age
13 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Schools in Ciudad Real (Castilla-La Mancha region) with at least one classroom in both 5rd and 6th grades of Primary Education. * Schools currently involved in educational innovation projects that aim to transform classrooms and apply student-centered pedagogical approaches. * Schools whose School Council has approved participation in the MOVI-OLE! intervention and in baseline and final evaluations. * Students enrolled in 5rd or 6th grade of Primary Education. * Students without any condition that, according to families, pediatricians, or teachers, prevents participation in the MOVI-OLE! intervention. * Students with signed informed consent from a parent or legal guardian for participation in the study activities and assessments. * Students who verbally agree to participate in baseline and final physical assessments.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Social and Health Research Center. Universidad de Castilla-La Mancha Cuenca Cuenca

More University of Castilla-La Mancha trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07103343 on ClinicalTrials.gov ↗ ← All trials in Spain